SIC 2836 - Biological Products, (No Diagnostic Substances)
Companies
- ADMA - ADMA BIOLOGICS, INC.
- ADPT - Adaptive Biotechnologies Corp
- ALEC - Alector, Inc.
- ALLO - Allogene Therapeutics, Inc.
- AMGN - AMGEN INC
- APGE - Apogee Therapeutics, Inc.
- ATYR - aTYR PHARMA INC
- AURA - Aura Biosciences, Inc.
- AVXL - ANAVEX LIFE SCIENCES CORP.
- BCRX - BIOCRYST PHARMACEUTICALS INC
- BEAM - Beam Therapeutics Inc.
- BIIB - BIOGEN INC.
- CADL - Candel Therapeutics, Inc.
- CGEM - Cullinan Therapeutics, Inc.
- CGON - CG Oncology, Inc.
- CHRS - Coherus Oncology, Inc.
- CMPX - Compass Therapeutics, Inc.
- CRDF - Cardiff Oncology, Inc.
- CRSP - CRISPR Therapeutics AG
- DNA - Ginkgo Bioworks Holdings, Inc.
- DNLI - Denali Therapeutics Inc.
- EDIT - Editas Medicine, Inc.
- EXEL - EXELIXIS, INC.
- FATE - FATE THERAPEUTICS INC
- FDMT - 4D Molecular Therapeutics, Inc.
- FENC - FENNEC PHARMACEUTICALS INC.
- GILD - GILEAD SCIENCES, INC.
- GLUE - Monte Rosa Therapeutics, Inc.
- HALO - HALOZYME THERAPEUTICS, INC.
- HUMA - Humacyte, Inc.
- IBRX - ImmunityBio, Inc.
- IKT - Inhibikase Therapeutics, Inc.
- IMVT - Immunovant, Inc.
- INBX - Inhibrx Biosciences, Inc.
- INMB - Inmune Bio, Inc.
- IOVA - IOVANCE BIOTHERAPEUTICS, INC.
- KOD - Kodiak Sciences Inc.
- KRYS - Krystal Biotech, Inc.
- KYMR - Kymera Therapeutics, Inc.
- LENZ - LENZ Therapeutics, Inc.
- LXEO - Lexeo Therapeutics, Inc.
- MAZE - Maze Therapeutics, Inc.
- MGTX - MeiraGTx Holdings plc
- MRNA - Moderna, Inc.
- NBIX - NEUROCRINE BIOSCIENCES INC
- NVAX - NOVAVAX INC
- PCVX - Vaxcyte, Inc.
- PRME - Prime Medicine, Inc.
- REPL - Replimune Group, Inc.
- RGEN - REPLIGEN CORP
- RGNX - REGENXBIO Inc.
- RLAY - Relay Therapeutics, Inc.
- RVMD - Revolution Medicines, Inc.
- RXRX - RECURSION PHARMACEUTICALS, INC.
- SANA - Sana Biotechnology, Inc.
- SLDB - Solid Biosciences Inc.
- SRRK - Scholar Rock Holding Corp
- TARA - Protara Therapeutics, Inc.
- TARS - Tarsus Pharmaceuticals, Inc.
- TECH - BIO-TECHNE Corp
- TECX - Tectonic Therapeutic, Inc.
- TSHA - Taysha Gene Therapies, Inc.
- TVGN - Tevogen Bio Holdings Inc.
- TWST - Twist Bioscience Corp
- VCEL - Vericel Corp
- VIR - Vir Biotechnology, Inc.
- VYGR - Voyager Therapeutics, Inc.
Related Macro Threads
- Inflation (CPI / PCE / PPI) - 10 indicators, 3 mapped SIC sectors
- US labor market - 12 indicators, 3 mapped SIC sectors
- Growth & output - 13 indicators, 4 mapped SIC sectors
- Money & trade - 2 indicators, 4 mapped SIC sectors
- Government finances - 6 indicators, 3 mapped SIC sectors
- Sector employment - 5 indicators, 5 mapped SIC sectors
- Industrial orders & inventories - 3 indicators, 3 mapped SIC sectors
- Trade & external - 4 indicators, 4 mapped SIC sectors
Macro Context
- INDPRO - Industrial Production: Total Index
- TCU - Capacity Utilization: Total Index
- PPIACO - Producer Price Index by Commodity: All Commodities
- GDPC1 - Real Gross Domestic Product
- DGS10 - Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- FEDFUNDS - Federal Funds Effective Rate
- CES0500000003 - Average Hourly Earnings of All Employees, Total Private
- PAYEMS - All Employees, Total Nonfarm
Sector financials
Peer figures are build-time aggregates of the SEC companyfacts financials already shown on member company pages. As of latest member filing date: 2026-05-20.
| Companies With Data | Companies With Revenue | Aggregate Revenue | Median Revenue | Median Net Margin | Median Operating Margin | Median Revenue Growth | Median Diluted EPS |
|---|---|---|---|---|---|---|---|
| 67 | 44 | 92,386,159,000 | 118,480,000 | -20.63% | -16.81% | 20.32% | -1.37 |
Charts
Member companies by reported revenue
Net margin distribution
Peer Table
| Company | Latest Revenue | Revenue FY | Net Margin | Operating Margin | Revenue Growth | Diluted EPS |
|---|---|---|---|---|---|---|
| AMGN - AMGEN INC | 36,751,000,000 | 2025 | 20.98% | 24.71% | 9.95% | 14.23 |
| GILD - GILEAD SCIENCES, INC. | 29,443,000,000 | 2025 | 28.90% | 34.04% | 2.40% | 6.78 |
| BIIB - BIOGEN INC. | 9,890,600,000 | 2025 | 13.07% | 2.22% | 8.79 | |
| NBIX - NEUROCRINE BIOSCIENCES INC | 2,860,500,000 | 2025 | 16.73% | 21.64% | 21.45% | 4.67 |
| EXEL - EXELIXIS, INC. | 2,320,126,000 | 2026 | 33.73% | 37.59% | 6.98% | 2.78 |
| MRNA - Moderna, Inc. | 1,944,000,000 | 2025 | -145.16% | -121.91% | -39.93% | -7.26 |
| HALO - HALOZYME THERAPEUTICS, INC. | 1,396,611,000 | 2025 | 22.69% | 33.58% | 37.55% | 2.56 |
| TECH - BIO-TECHNE Corp | 1,219,635,000 | 2025 | 6.02% | 8.38% | 5.23% | 0.46 |
| NVAX - NOVAVAX INC | 1,123,479,000 | 2025 | 39.19% | 40.30% | 64.69% | 2.58 |
| BCRX - BIOCRYST PHARMACEUTICALS INC | 874,837,000 | 2025 | 30.16% | 38.98% | 94.10% | 1.21 |
| RGEN - REPLIGEN CORP | 738,256,000 | 2025 | 6.62% | 7.47% | 16.36% | 0.86 |
| ADMA - ADMA BIOLOGICS, INC. | 510,173,000 | 2025 | 28.80% | 37.53% | 19.63% | 0.60 |
| TARS - Tarsus Pharmaceuticals, Inc. | 451,360,000 | 2025 | -14.72% | -15.72% | 146.71% | -1.59 |
| KRYS - Krystal Biotech, Inc. | 389,130,000 | 2025 | 52.64% | 41.45% | 33.94% | 6.84 |
| TWST - Twist Bioscience Corp | 376,572,000 | 2025 | -20.63% | -36.18% | 20.32% | -1.30 |
| ADPT - Adaptive Biotechnologies Corp | 276,976,000 | 2025 | -21.48% | -20.62% | 54.77% | -0.39 |
| VCEL - Vericel Corp | 276,259,000 | 2025 | 5.98% | 4.00% | 16.45% | 0.32 |
| IOVA - IOVANCE BIOTHERAPEUTICS, INC. | 263,502,000 | 2025 | -148.38% | 60.60% | -1.09 | |
| RGNX - REGENXBIO Inc. | 170,441,000 | 2025 | -113.75% | -94.58% | 104.54% | -3.76 |
| DNA - Ginkgo Bioworks Holdings, Inc. | 170,155,000 | 2025 | -132.14% | -25.06% | -5.64 | |
| BEAM - Beam Therapeutics Inc. | 139,743,000 | 2025 | -57.24% | -46.73% | 120.01% | -0.81 |
| GLUE - Monte Rosa Therapeutics, Inc. | 123,672,000 | 2025 | -31.23% | -43.83% | 63.54% | |
| IBRX - ImmunityBio, Inc. | 113,288,000 | 2025 | 668.31% | -0.38 | ||
| FDMT - 4D Molecular Therapeutics, Inc. | 85,209,000 | 2025 | 230194.59% | -2.42 | ||
| MGTX - MeiraGTx Holdings plc | 81,391,000 | 2025 | -140.31% | -130.20% | 144.57% | -1.42 |
| RXRX - RECURSION PHARMACEUTICALS, INC. | 74,681,000 | 2025 | 26.92% | -1.44 | ||
| VIR - Vir Biotechnology, Inc. | 68,556,000 | 2025 | 31.92% | 51.56% | -7.61% | -3.16 |
| FENC - FENNEC PHARMACEUTICALS INC. | 44,642,000 | 2025 | -21.82% | -14.07% | -6.09% | -0.34 |
| EDIT - Editas Medicine, Inc. | 40,520,000 | 2025 | -127.82% | -148.61% | 25.39% | -1.80 |
| VYGR - Voyager Therapeutics, Inc. | 40,374,000 | 2025 | -81.25% | -104.11% | -49.53% | -2.04 |
| KYMR - Kymera Therapeutics, Inc. | 39,211,000 | 2025 | -137.60% | -138.03% | -16.70% | -3.69 |
| ALEC - Alector, Inc. | 21,045,000 | 2025 | -118.39% | -144.19% | -79.07% | -1.39 |
| LENZ - LENZ Therapeutics, Inc. | 19,088,000 | 2025 | -2.85 | |||
| RLAY - Relay Therapeutics, Inc. | 15,355,000 | 2025 | -63.41% | -67.51% | 53.44% | -1.61 |
| TSHA - Taysha Gene Therapies, Inc. | 9,773,000 | 2025 | 17.28% | -0.34 | ||
| FATE - FATE THERAPEUTICS INC | 6,646,000 | 2025 | -51.24% | -1.15 | ||
| PRME - Prime Medicine, Inc. | 4,632,000 | 2025 | -65.45% | -17.89% | 55.28% | -1.35 |
| CGON - CG Oncology, Inc. | 4,040,000 | 2025 | 254.70% | -2.08 | ||
| CRSP - CRISPR Therapeutics AG | 3,510,000 | 2025 | -41.38% | -59.95% | -90.59% | -6.47 |
| HUMA - Humacyte, Inc. | 2,038,000 | 2025 | -0.26 | |||
| INBX - Inhibrx Biosciences, Inc. | 1,300,000 | 2025 | -9.04 | |||
| CRDF - Cardiff Oncology, Inc. | 593,000 | 2025 | -13.18% | -0.69 | ||
| ATYR - aTYR PHARMA INC | 190,000 | 2025 | -19.15% | -0.80 | ||
| INMB - Inmune Bio, Inc. | 50,000 | 2025 | 257.14% | -1.86 | ||
| ALLO - Allogene Therapeutics, Inc. | -0.87 | |||||
| APGE - Apogee Therapeutics, Inc. | -4.22 | |||||
| AURA - Aura Biosciences, Inc. | -1.76 | |||||
| AVXL - ANAVEX LIFE SCIENCES CORP. | -0.54 | |||||
| CADL - Candel Therapeutics, Inc. | -0.72 | |||||
| CGEM - Cullinan Therapeutics, Inc. | ||||||
| CHRS - Coherus Oncology, Inc. | 1.43 | |||||
| CMPX - Compass Therapeutics, Inc. | ||||||
| DNLI - Denali Therapeutics Inc. | -2.97 | |||||
| IKT - Inhibikase Therapeutics, Inc. | -0.49 | |||||
| IMVT - Immunovant, Inc. | -2.77 | |||||
| KOD - Kodiak Sciences Inc. | -4.32 | |||||
| LXEO - Lexeo Therapeutics, Inc. | -1.86 | |||||
| MAZE - Maze Therapeutics, Inc. | -3.05 | |||||
| PCVX - Vaxcyte, Inc. | -5.63 | |||||
| REPL - Replimune Group, Inc. | -3.07 | |||||
| RVMD - Revolution Medicines, Inc. | -5.95 | |||||
| SANA - Sana Biotechnology, Inc. | -0.96 | |||||
| SLDB - Solid Biosciences Inc. | -1.99 | |||||
| SRRK - Scholar Rock Holding Corp | -3.29 | |||||
| TARA - Protara Therapeutics, Inc. | -1.34 | |||||
| TECX - Tectonic Therapeutic, Inc. | -4.05 | |||||
| TVGN - Tevogen Bio Holdings Inc. | -8.08 |
Sources
Macro Data
- INDPRO - FRED series INDPRO, source: Board of Governors of the Federal Reserve System
- TCU - FRED series TCU, source: Board of Governors of the Federal Reserve System
- PPIACO - FRED series PPIACO, source: U.S. Bureau of Labor Statistics
- GDPC1 - FRED series GDPC1, source: U.S. Bureau of Economic Analysis
- DGS10 - FRED series DGS10, source: Board of Governors / U.S. Treasury market data
- FEDFUNDS - FRED series FEDFUNDS, source: Board of Governors of the Federal Reserve System
- CES0500000003 - FRED series CES0500000003, source: U.S. Bureau of Labor Statistics
- PAYEMS - FRED series PAYEMS, source: U.S. Bureau of Labor Statistics
SEC Data
- ADMA SEC company page; latest 10-K 0001140361-26-006815; latest 10-Q 0001140361-26-019336
- ADPT SEC company page; latest 10-K 0001193125-26-076902; latest 10-Q 0001193125-26-206546
- ALEC SEC company page; latest 10-K 0001193125-26-071593; latest 10-Q 0001193125-26-211981
- ALLO SEC company page; latest 10-K 0001628280-26-017242; latest 10-Q 0001628280-26-034585
- AMGN SEC company page; latest 10-K 0000318154-26-000010; latest 10-Q 0000318154-26-000057
- APGE SEC company page; latest 10-K 0001974640-26-000002; latest 10-Q 0001193125-26-215698
- ATYR SEC company page; latest 10-K 0001339970-26-000008; latest 10-Q 0001339970-26-000033
- AURA SEC company page; latest 10-K 0001193125-26-130401; latest 10-Q 0001193125-26-216808
- AVXL SEC company page; latest 10-K 0001731122-25-001596; latest 10-Q 0001731122-26-000200
- BCRX SEC company page; latest 10-K 0001628280-26-012240; latest 10-Q 0001628280-26-031238
- BEAM SEC company page; latest 10-K 0001193125-26-065194; latest 10-Q 0001193125-26-210338
- BIIB SEC company page; latest 10-K 0000875045-26-000013; latest 10-Q 0000875045-26-000045
- CADL SEC company page; latest 10-K 0001193125-26-103134; latest 10-Q 0001193125-26-222904
- CGEM SEC company page; latest 10-K 0001193125-26-099362; latest 10-Q 0001193125-26-210304
- CGON SEC company page; latest 10-K 0001193125-26-079498; latest 10-Q 0001193125-26-214669
- CHRS SEC company page; latest 10-K 0001104659-26-025308; latest 10-Q 0001104659-26-058703
- CMPX SEC company page; latest 10-K 0001171843-26-001337; latest 10-Q 0001171843-26-003006
- CRDF SEC company page; latest 10-K 0001193125-26-067464; latest 10-Q 0001213037-26-000011
- CRSP SEC company page; latest 10-K 0001193125-26-048957; latest 10-Q 0001193125-26-204188
- DNA SEC company page; latest 10-K 0001628280-26-012346; latest 10-Q 0001628280-26-032116
- DNLI SEC company page; latest 10-K 0001714899-26-000021; latest 10-Q 0001714899-26-000064
- EDIT SEC company page; latest 10-K 0001650664-26-000017; latest 10-Q 0001650664-26-000045
- EXEL SEC company page; latest 10-K 0000939767-26-000021; latest 10-Q 0000939767-26-000059
- FATE SEC company page; latest 10-K 0001193125-26-073699; latest 10-Q 0001193125-26-220696
- FDMT SEC company page; latest 10-K 0001193125-26-114075; latest 10-Q 0001193125-26-211939
- FENC SEC company page; latest 10-K 0001104659-26-036182; latest 10-Q 0001104659-26-061213
- GILD SEC company page; latest 10-K 0000882095-26-000006; latest 10-Q 0000882095-26-000024
- GLUE SEC company page; latest 10-K 0001193125-26-109360; latest 10-Q 0001193125-26-210358
- HALO SEC company page; latest 10-K 0001159036-26-000024; latest 10-Q 0001159036-26-000068
- HUMA SEC company page; latest 10-K 0001818382-26-000004; latest 10-Q 0001193125-26-221755
- IBRX SEC company page; latest 10-K 0001326110-26-000030; latest 10-Q 0001326110-26-000059
- IKT SEC company page; latest 10-K 0001193125-26-126371; latest 10-Q 0001193125-26-219641
- IMVT SEC company page; latest 10-K 0001764013-26-000064; latest 10-Q 0001764013-26-000011
- INBX SEC company page; latest 10-K 0002007919-26-000006; latest 10-Q 0002007919-26-000027
- INMB SEC company page; latest 10-K 0001213900-26-036370; latest 10-Q 0001213900-26-053338
- IOVA SEC company page; latest 10-K 0001104659-26-018899; latest 10-Q 0001104659-26-056778
- KOD SEC company page; latest 10-K 0001193125-26-134887; latest 10-Q 0001193125-26-211951
- KRYS SEC company page; latest 10-K 0001711279-26-000016; latest 10-Q 0001711279-26-000043
- KYMR SEC company page; latest 10-K 0001193125-26-073395; latest 10-Q 0001193125-26-193967
- LENZ SEC company page; latest 10-K 0001815776-26-000011; latest 10-Q 0001815776-26-000037
- LXEO SEC company page; latest 10-K 0001193125-26-132085; latest 10-Q 0001193125-26-215678
- MAZE SEC company page; latest 10-K 0001193125-26-122778; latest 10-Q 0001193125-26-219430
- MGTX SEC company page; latest 10-K 0001104659-26-036494; latest 10-Q 0001104659-26-060739
- MRNA SEC company page; latest 10-K 0001682852-26-000033; latest 10-Q 0001682852-26-000060
- NBIX SEC company page; latest 10-K 0000914475-26-000007; latest 10-Q 0000914475-26-000026
- NVAX SEC company page; latest 10-K 0001000694-26-000007; latest 10-Q 0001628280-26-030917
- PCVX SEC company page; latest 10-K 0001649094-26-000007; latest 10-Q 0001649094-26-000017
- PRME SEC company page; latest 10-K 0001628280-26-013569; latest 10-Q 0001628280-26-031726
- REPL SEC company page; latest 10-K 0001737953-25-000009; latest 10-Q 0001628280-26-004805
- RGEN SEC company page; latest 10-K 0001193125-26-076528; latest 10-Q 0001193125-26-208954
- RGNX SEC company page; latest 10-K 0001193125-26-094013; latest 10-Q 0001193125-26-222804
- RLAY SEC company page; latest 10-K 0001193125-26-076739; latest 10-Q 0001193125-26-206454
- RVMD SEC company page; latest 10-K 0001193125-26-071563; latest 10-Q 0001193125-26-208969
- RXRX SEC company page; latest 10-K 0001601830-26-000039; latest 10-Q 0001601830-26-000078
- SANA SEC company page; latest 10-K 0001193125-26-088215; latest 10-Q 0001193125-26-216769
- SLDB SEC company page; latest 10-K 0001193125-26-115928; latest 10-Q 0001193125-26-219337
- SRRK SEC company page; latest 10-K 0001104659-26-022551; latest 10-Q 0001104659-26-056667
- TARA SEC company page; latest 10-K 0001213900-26-025433; latest 10-Q 0001213900-26-055463
- TARS SEC company page; latest 10-K 0001819790-26-000019; latest 10-Q 0001819790-26-000038
- TECH SEC company page; latest 10-K 0001558370-25-011716; latest 10-Q 0001104659-26-056302
- TECX SEC company page; latest 10-K 0001193125-26-076793; latest 10-Q 0001193125-26-212016
- TSHA SEC company page; latest 10-K 0001193125-26-115202; latest 10-Q 0001193125-26-207666
- TVGN SEC company page; latest 10-K 0001493152-26-014326; latest 10-Q 0001493152-26-023920
- TWST SEC company page; latest 10-K 0001581280-25-000025; latest 10-Q 0001581280-26-000040
- VCEL SEC company page; latest 10-K 0001628280-26-012013; latest 10-Q 0001628280-26-031742
- VIR SEC company page; latest 10-K 0001628280-26-010749; latest 10-Q 0001628280-26-031471
- VYGR SEC company page; latest 10-K 0001104659-26-025197; latest 10-Q 0001104659-26-057097